Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001108205-26-000061
Filing Date
2026-05-13
Accepted
2026-05-13 09:20:43
Documents
56
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cris-20260331.htm   iXBRL 10-Q 817685
2 EX-31.1 cris-3312026x10qexx311.htm EX-31.1 10636
3 EX-31.2 cris-3312026x10qexx312.htm EX-31.2 10590
4 EX-32.1 cris-3312026x10qexx321.htm EX-32.1 4678
5 EX-32.2 cris-3312026x10qexx322.htm EX-32.2 4641
  Complete submission text file 0001108205-26-000061.txt   5102486

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cris-20260331.xsd EX-101.SCH 40475
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cris-20260331_cal.xml EX-101.CAL 36530
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cris-20260331_def.xml EX-101.DEF 182300
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cris-20260331_lab.xml EX-101.LAB 582266
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cris-20260331_pre.xml EX-101.PRE 374957
60 EXTRACTED XBRL INSTANCE DOCUMENT cris-20260331_htm.xml XML 583177
Mailing Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421 617-503-6500
CURIS INC (Filer) CIK: 0001108205 (see all company filings)

EIN.: 043505116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30347 | Film No.: 26971289
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)